IRhythm Technologies Ownership
| IRTC Stock | USD 184.12 1.17 0.63% |
Shares in Circulation | First Issued 2014-12-31 | Previous Quarter 31.6 M | Current Value 31.6 M | Avarage Shares Outstanding 24.4 M | Quarterly Volatility 8 M |
IRhythm Stock Ownership Analysis
About 99.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 2.93. iRhythm Technologies had not issued any dividends in recent years. iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram monitoring products for patients at risk for arrhythmias in the United States. The company was incorporated in 2006 and is headquartered in San Francisco, California. Irhythm Technologies operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 1700 people. To learn more about iRhythm Technologies call Quentin Blackford at 415 632 5700 or check out https://www.irhythmtech.com.IRhythm Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as IRhythm Technologies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading iRhythm Technologies backward and forwards among themselves. IRhythm Technologies' institutional investor refers to the entity that pools money to purchase IRhythm Technologies' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Champlain Investment Partners, Llc | 2025-06-30 | 661.2 K | Ubs Asset Mgmt Americas Inc | 2025-06-30 | 607.7 K | Fuller & Thaler Asset Management Inc | 2025-06-30 | 586.5 K | Bessemer Group Inc | 2025-06-30 | 569.2 K | Jpmorgan Chase & Co | 2025-06-30 | 563.2 K | Stephens Inv Mgmt Group Llc | 2025-06-30 | 552.9 K | Allspring Global Investments Holdings, Llc | 2025-06-30 | 434.3 K | Fmr Inc | 2025-06-30 | 420.2 K | Wellington Management Company Llp | 2025-06-30 | 395.3 K | Vanguard Group Inc | 2025-06-30 | 3.2 M | Sands Capital Management, Llc | 2025-06-30 | 2.9 M |
iRhythm Technologies Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific IRhythm Technologies insiders, such as employees or executives, is commonly permitted as long as it does not rely on IRhythm Technologies' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases IRhythm Technologies insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
IRhythm Technologies' latest congressional trading
Congressional trading in companies like iRhythm Technologies, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in IRhythm Technologies by those in governmental positions are based on the same information available to the general public.
| 2025-09-12 | Senator Richard Blumenthal | Acquired Under $15K | Verify |
IRhythm Technologies Outstanding Bonds
IRhythm Technologies issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. iRhythm Technologies uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most IRhythm bonds can be classified according to their maturity, which is the date when iRhythm Technologies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
IRhythm Technologies Corporate Filings
8K | 30th of October 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 4th of September 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 13th of August 2025 Other Reports | ViewVerify | |
F3 | 8th of July 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether iRhythm Technologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IRhythm Technologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Irhythm Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Irhythm Technologies Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iRhythm Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For information on how to trade IRhythm Stock refer to our How to Trade IRhythm Stock guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IRhythm Technologies. If investors know IRhythm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IRhythm Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.93) | Revenue Per Share | Quarterly Revenue Growth 0.261 | Return On Assets | Return On Equity |
The market value of iRhythm Technologies is measured differently than its book value, which is the value of IRhythm that is recorded on the company's balance sheet. Investors also form their own opinion of IRhythm Technologies' value that differs from its market value or its book value, called intrinsic value, which is IRhythm Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IRhythm Technologies' market value can be influenced by many factors that don't directly affect IRhythm Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IRhythm Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if IRhythm Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IRhythm Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.